See also this year's filing and all EDGAR filings for this company.
PDF Report 0001641640_2017_Nabriva_Therapeutics_plc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001641640')"} |
Graph
Absolute values for 0001641640, Nabriva Therapeutics plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 90,621,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 270,000 |
| 2 | PropertyPlantAndEquipmentNet | 519,000 |
| 3 | remainder_Assets | 1,830,000 |
| 4 | LiabilitiesCurrent | 15,877,000 |
| 5 | LiabilitiesNoncurrent | 107,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,535,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 47,397,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 6,042,000 |
| 13 | remainder_ComprehensiveNetIncome | 50,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 93,240,000 |
| 1 | Liabilities | 15,984,000 |
| 2 | Expenses | 60,932,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 77,256,000 |
| 5 | NetIncome | -54,890,000 |
| 6 | ComprehensiveNetIncome | -54,865,000 |
| 7 | BaseVar | 88,124,000 |
| 8 | EconomicCapitalRatio | 1.43 |
Edgar->Model Mapping
Feature Distribution
